Effect Of Maternal Immunization Research Articles

Modeling Variability in Immunocompetence and Immunoresponsiveness

The purposes of this paper were to 1) develop a stochastic model that would reflect observed variation between animals and across ages in immunocompetence and responsiveness; and 2) illustrate consequences of this variability for the statistical power of genotype comparisons and selection. A stochastic model of immunocompetence development and responsiveness kinetics was developed. This model enabled variability in immunological variables to be taken into account in the evaluation of challenge and measurement strategies for selection. The characteristics of the variation in model output reflect those observed in the literature, to the extent that variation in the literature shows a consistent pattern; knowledge of true variation and patterns of variation in immunological variables is limited. The model created correlations between immunocompetence and immunoresponsiveness components, as well as correlations within each component across time. These correlations were generally in agreement with literature estimates, where available. The model enabled predictions of the effectiveness of selection for improved health through immunocompetence or immunoresponsiveness. It was predicted that effective selection for increased general immunocompetence to improve health should be done only when baseline immunity has matured. Further, the model implied that selection is unlikely to be successful if it is based only on a single measurement. Problems with low statistical power to detect differences between genotypes can be reduced by increasing challenge age in the experimental design, and one should ensure that the effects of maternal immunity are minimal when the challenge is done. The ability to detect differences between different groups of animals differs substantially with measurement timing because of low repeatabilities of immunocompetence and responsiveness across time. In general, the probability of detecting differences becomes higher when the challenge age is increased. Consequently, both the age at selection and the age at which information is gathered for selection must be considered carefully when designing genetic evaluations.

Evidence of an interannual effect of maternal immunization on the immune response of juveniles in a long‐lived colonial bird

Little is known about the maternal transfer of antibodies in natural host-parasite systems despite its possible evolutionary and ecological implications. In domestic animals, the maternal transfer of antibodies can enhance offspring survival via a temporary protection against parasites, but it can also interfere with the juvenile immune response to antigens. We tested the functional role of maternal antibodies in a natural population of a long-lived colonial seabird, the kittiwake (Rissa tridactyla), using a vaccine (Newcastle disease virus vaccine) to mimic parasite exposure combined with a cross-fostering design. We first investigated the role of prior maternal exposure on the interannual transmission of Ab to juveniles. We then tested the effect of these antibodies on the juvenile immune response to the same antigen. The results show that specific maternal antibodies were transferred to chicks 1 year after maternal exposure and that these antibodies were functional, i.e. they affected juvenile immunity. These results suggest that the role of maternal antibodies may depend on the timing and pattern of offspring exposure to parasites, along with the patterns of maternal exposure and the dynamics of her immune response. Overall, our approach underlines that although the transgenerational transfer of antibodies in natural populations is likely to have broad implications, the nature of these effects may vary dramatically among host-parasite systems, depending on the physiological mechanisms involved and the ecological context.

Maternal vaccination against subclinical necrotic enteritis in broilers

The inclusion of antibacterial feed additives has until now been the major strategy for controlling Clostridium perfringens-associated necrotic enteritis in broilers. In the present study, the effect of maternal immunization against the disease was examined. Broiler breeder hens were injected intramuscularly with candidate vaccines based on C. perfringens type A and type C toxoids adjuvanted with aluminium hydroxide. Vaccination resulted in a strong serum immunoglobulin G response to C. perfringens alpha-toxin in parent hens, and specific antibodies were transferred to their progeny. Subclinical necrotic enteritis in broilers was induced under field conditions or in a disease model, and the occurrence of specific enteric and hepatic lesions was evaluated in randomly selected birds. In three experiments, estimates of odds ratio for developing such lesions were 0.23, 0.33 and 0.56 in maternally toxoid C-immunized broilers compared with non-immunized controls. In toxoid A-immunized birds, odds ratios were estimated at 0.41, 0.61 and 0.63. From these results, immunoprophylaxis seems to be an interesting alternative for the control of necrotic enteritis in broilers.

Effect of maternal immunity on the immune response to oral vaccination against rabies in young foxes

To determine effect of maternal antibodies on immune response to oral vaccination against rabies in young foxes. 250 cubs from 48 vixens. Sera were obtained from cubs of 36 vaccinated (maternally vaccinated [MV+]) and 12 nonvaccinated (MV-) vixens between 23 and 71 days of age and tested for neutralizing antibodies. Seventy-one MV+ cubs and 33 MV-cubs were vaccinated orally with modified-live virus vaccine SAD B19. Geometric mean titer (GMT) was determined in these cubs approximately 21, 39, and 57 days after vaccination. In a subsequent experiment, 10 vaccinated MV+ cubs, 6 vaccinated MV- cubs, and 6 control cubs were challenge inoculated with virulent rabies virus approximately 100 days after vaccination. Serum GMT of nonvaccinated MV cubs (0.23 U/ml) was significantly greater than that of non-vaccinated MV- cubs (0.15 U/ml). The GMT of vaccinated MV+ cubs 21, 39, and 57 days after vaccination were 2.85, 2.11, and 0.79 U/ml, respectively, and were significantly less than those of vaccinated MV- cubs (12.19, 6.76, and 4.02 U/ml, respectively). All challenge-inoculated cubs with GMT < 0.5 U/ml succumbed to rabies. Partially impaired immune response in cubs < 8 weeks old from vaccinated vixens causes insufficient protection against rabies. Inhibition of the immune response persists longer than the period during which maternal antibodies are detectable. Thus, oral vaccination campaigns for young foxes in areas where vaccination has been performed need to be reconsidered.

Male survival in a hostile world: The effect of maternal immunity to H-Y

Male survival in a hostile world: The effect of maternal immunity to H-Y

Maternal Immunization With Haemophilus influenzae Type b Polysaccharide—Tetanus Protein Conjugate Vaccine in The Gambia

To evaluate maternal responses to Haemophilus influenzae type b (Hib) polysaccharide-tetanus protein conjugate (polyribosylribitol phosphate-tetanus or PRP-T) given to pregnant Gambian women, the transplacental transfer of antibody, and the effect of maternal immunization on infant responses to the vaccine. An open, randomized immunogenicity study. A busy urban health center in The Gambia. A total of 451 pregnant women enrolled during the third trimester of pregnancy. Study participants were randomized to three groups. In one group, mothers were given PRP-T during the third trimester and their infants were given PRP-T at 2, 3, and 4 months of age. In the second group, mothers received PRP-T and infants were given inactivated poliovirus vaccine. In the third group, mothers received meningococcal A and C vaccine, and their infants received PRP-T. Anti-PRP antibody measurements of maternal cord, and infant blood. Vaccinated women had a marked increase in total anti-PRP antibody (geometric mean titer 9.0 micrograms/mL), which was greatest in women in their first or second pregnancy. Previous tetanus vaccination during the same pregnancy and high concentrations of antitetanus antibody were associated with lower anti-PRP responses. In infants of PRP-T recipients, cord blood anti-PRP IgG concentrations were 61% of simultaneous maternal concentrations. In vaccinated infants of vaccinated mothers, geometric mean anti-PRP antibody concentrations at birth, 2 months of age, and 5 months of age were 1.92, 0.35 and 2.84 micrograms/mL, respectively, while in vaccinated infants of unvaccinated mothers, the corresponding concentrations were 0.29, 0.12, and 3.91 micrograms/mL. At 2 months of age, 60% of infants of vaccinated mothers and 26% of infants of unvaccinated mothers had anti-PRP antibody concentrations considered to be protective (>0.15 micrograms/mL). In areas where much invasive Hib disease occurs in infants younger than 6 months, maternal immunization may help to reduce the risk of Hib disease in infants too young for immunization.

Effect of maternal immunization with oral poliovirus vaccine on neonatal immunity.

During the summer of 1988, an outbreak of poliomyelitis caused by poliovirus 1 occurred in Israel, during which a national mass immunization campaign with oral poliovirus was undertaken. This prospective study was undertaken to assess the effect of maternal oral poliovirus immunization during the third trimester of pregnancy on neonatal immunity against poliovirus. Cord blood specimens of 88 neonates, born 2 to 7 weeks after maternal immunization, were examined for antipoliovirus antibodies and compared with 100 samples obtained from neonates 7 months before the outbreak. Blood samples were also obtained from the 62 mothers of neonates who had been immunized 2 to 5 weeks before delivery. Sera were tested for neutralizing antibodies to the 3 poliovirus types using a microneutralization technique. The geometric mean titer to poliovirus type 1 was significantly higher in neonates whose mothers were immunized during pregnancy (87.1) than in the offspring of the nonvaccinated group (53.0), P < 0.05. Two to 3 weeks after immunization, geometric mean titers against all 3 poliovirus types were higher in maternal blood than in cord blood whereas 4 to 5 weeks after vaccination a significant difference was found for type 3 only. Although oral poliovirus immunization during pregnancy resulted in higher neonatal antibody titers to poliovirus type 1, the proportion of newborns with titers of < 1:8 to the 3 poliovirus types did not change significantly.

Maternal immunization and the immune response of neonates to pneumococcal polysaccharides.

The effect of maternal immunization on the immune response of neonates to pneumococcal polysaccharides and the characterization of IgG receptor molecules have been reviewed and studied. Maternal immunization with pneumococcal 19F polysaccharide during gestation and/or lactation induces a significantly stronger response in offspring. When young mice born to pregnant mice immunized with a polysaccharide-protein conjugate (e.g., 19F polysaccharide-human IgG) are given an additional dose of polysaccharide-protein conjugate immunogen, they develop an antibody response stronger than that of young mice not receiving additional immunogen. Injection of female mice (before their mating) with type 19F or type 3 polysaccharide may also induce a stronger antibody response in offspring. Combined passive immunization with immunoglobulin and active immunization do not cause suppression or observable harmful immunologic effects; rather, such immunization may elicit sufficient 19F antibody formation for protection against infection during early life. IgG receptor molecules have been isolated from rabbit yolk-sac membranes, and their physicochemical properties have been characterized.

Effects of Maternal Immunization on the Survival and Postnatal Development of the Offspring

Immunization of females prior to mating altered the size of their litters and the incidence of postnatal death and runting, and the effect varied with the antigen used. Litter size was decreased after immunization with an aggregated synthetic polypeptide or with DNP-BGG, but not with aggregated insulin. Postnatal mortality was increased after immunization with an aggregated polypeptide, aggregated insulin or DNP-BGG. Postnatal runting was increased after immunization with the aggregated polypeptide or with aggregated insulin.

The Effect of Maternal Immunization against Organ Tissues on Embryonic Differentiation in the Mouse

ABSTRACT The response of embryonic differentiation to injection of organ-tissue-emulsion into female mice prior to conception was studied. The injection of brain-emulsion into females of the DBA/I strain was followed by abnormalities of the developing nervous system in 8–9 per cent, of subsequently conceived embryos. Such abnormalities consisted of suppression of nervous-tissue differentiation, microcephaly, and abnormalities of closure of neural folds. As controls, female sibs of brain-injected mothers were injected with a heart-emulsion. No nervous-system abnormalities were observed in the subsequently conceived embryos of these mothers. The possible mechanism of the effect described here is discussed. It seems most likely that maternal antibodies are responsible for the nervous-system abnormalities of the embryos. Problems of the transmission of these antibodies to the embryo and of the mechanism of their effect on embryonic differentiation are discussed.